P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
| Published in: | Retrovirology |
|---|---|
| Main Authors: | Ostrowski MA, Yue F, Stone GW, Ngai N, Liu J |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-10-01
|
Similar Items
Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
by: Dawei Cui, et al.
Published: (2019-01-01)
by: Dawei Cui, et al.
Published: (2019-01-01)
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
by: Ayaka Sato, et al.
Published: (2025-01-01)
by: Ayaka Sato, et al.
Published: (2025-01-01)
Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis
by: Xiaoling Zhou, et al.
Published: (2022-01-01)
by: Xiaoling Zhou, et al.
Published: (2022-01-01)
Activation of OX40 and CD27 Costimulatory Signalling in Sheep through Recombinant Ovine Ligands
by: José Manuel Rojas, et al.
Published: (2020-06-01)
by: José Manuel Rojas, et al.
Published: (2020-06-01)
Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy
by: Aliya I Sani, et al.
Published: (2021-07-01)
by: Aliya I Sani, et al.
Published: (2021-07-01)
Editorial Vol.06-N.02
by: Teresa Lousa
Published: (2019-12-01)
by: Teresa Lousa
Published: (2019-12-01)
v. 06, n. 02 (2011)
by: Editoria Carta Internacional
Published: (2011-12-01)
by: Editoria Carta Internacional
Published: (2011-12-01)
Non-viral-mediated gene transfer of OX40 ligand for tumor immunotherapy
by: Olga A. Rakitina, et al.
Published: (2024-06-01)
by: Olga A. Rakitina, et al.
Published: (2024-06-01)
Characterization of a canarypox virus from an outbreak among canaries (Serinus canaria domesticus) in Lebanon
by: Houssam Shaib, et al.
Published: (2018-01-01)
by: Houssam Shaib, et al.
Published: (2018-01-01)
Evaluation of concurrent vaccinations with recombinant canarypox
equine influenza virus and inactivated equine herpesvirus
vaccines
by: Dong-Ha Lee, et al.
Published: (2022-05-01)
by: Dong-Ha Lee, et al.
Published: (2022-05-01)
Breaking Immunological Tolerance through OX40 (CD134)
by: Pratima Bansal-Pakala, et al.
Published: (2001-01-01)
by: Pratima Bansal-Pakala, et al.
Published: (2001-01-01)
An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis
by: Kaviyon Sadrolashrafi, et al.
Published: (2024-03-01)
by: Kaviyon Sadrolashrafi, et al.
Published: (2024-03-01)
The Role of CD40/CD40 Ligand Interactions in Bone Marrow Granulopoiesis
by: Irene Mavroudi, et al.
Published: (2011-01-01)
by: Irene Mavroudi, et al.
Published: (2011-01-01)
In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody
by: James G. Krueger, et al.
Published: (2025-08-01)
by: James G. Krueger, et al.
Published: (2025-08-01)
Expediente Art&Sensorium Vol.06 N°02
by: José Eliézer Mikosz
Published: (2019-12-01)
by: José Eliézer Mikosz
Published: (2019-12-01)
Caecum OX40+CD4 T-cell subset associates with mucosal damage and key markers of disease in treated HIV-infection
by: Isaac Rosado-Sánchez, et al.
Published: (2023-12-01)
by: Isaac Rosado-Sánchez, et al.
Published: (2023-12-01)
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis—Focus on Rocatinlimab and Amlitelimab
by: Ana Maria Lé, et al.
Published: (2022-12-01)
by: Ana Maria Lé, et al.
Published: (2022-12-01)
OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia
by: Taizou Hirano, et al.
Published: (2016-03-01)
by: Taizou Hirano, et al.
Published: (2016-03-01)
A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation
by: Julien Villeneuve, et al.
Published: (2017-01-01)
by: Julien Villeneuve, et al.
Published: (2017-01-01)
Juozas Jurginis (1909 02 05 - 1994 07 06)
by: Edvardas Gudavičius
Published: (1996-12-01)
by: Edvardas Gudavičius
Published: (1996-12-01)
Juozas Jurginis (1909 02 05 - 1994 07 06)
by: Edvardas Gudavičius
Published: (1996-12-01)
by: Edvardas Gudavičius
Published: (1996-12-01)
OX40/OX40L as a Therapeutic Target in Atopic Dermatitis: A Scoping Review
by: Valenzuela F, et al.
Published: (2025-05-01)
by: Valenzuela F, et al.
Published: (2025-05-01)
OX40/OX40L in systemic lupus erythematosus: Association with disease activity and lupus nephritis
by: Farres Mohamed, et al.
Published: (2011-01-01)
by: Farres Mohamed, et al.
Published: (2011-01-01)
Residue-Specific Message Encoding in CD40-Ligand
by: Aditya Yashwant Sarode, et al.
Published: (2020-09-01)
by: Aditya Yashwant Sarode, et al.
Published: (2020-09-01)
Identification and characterisation of the CD40-ligand of Sigmodon hispidus.
by: Marsha S Russell, et al.
Published: (2018-01-01)
by: Marsha S Russell, et al.
Published: (2018-01-01)
Development of targeted adjuvants for HIV-1 vaccines
by: Jun Liu, et al.
Published: (2017-09-01)
by: Jun Liu, et al.
Published: (2017-09-01)
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives
by: Alba Guglielmo, et al.
Published: (2025-05-01)
by: Alba Guglielmo, et al.
Published: (2025-05-01)
OX40 (CD134) Expression on T Regulatory Cells Is Related to Serious Hypertensive Disorders in Pregnancy
by: Maciej Kwiatek, et al.
Published: (2023-10-01)
by: Maciej Kwiatek, et al.
Published: (2023-10-01)
NINA IVANOVNA TIKHOMIROVA (14. 06. 1939 — 08. 02. 2013)
Published: (2016-02-01)
Published: (2016-02-01)
Grigoriev Valentin Mikhailovich (05.06.1920-12.02.2024)
by: article Editorial
Published: (2024-05-01)
by: article Editorial
Published: (2024-05-01)
Leonid I. Dvoretsky (19.06.1940–07.02.2024)
by: Board Editorial
Published: (2024-05-01)
by: Board Editorial
Published: (2024-05-01)
P02.06. The effect of massage therapy for breast surgery patients
by: Drackley N, et al.
Published: (2012-06-01)
by: Drackley N, et al.
Published: (2012-06-01)
06.02 AORTIC AND CAROTID STIFFNESS IN OLDER ADULTS. THE ROTTERDAM STUDY
by: F.U.S. Mattace-Raso, et al.
Published: (2007-08-01)
by: F.U.S. Mattace-Raso, et al.
Published: (2007-08-01)
Cover_252
Published: (2025-04-01)
Published: (2025-04-01)
Incomplete Freund’s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment
by: Ileana S Mauldin, et al.
Published: (2020-05-01)
by: Ileana S Mauldin, et al.
Published: (2020-05-01)
An in vitro Co-culture System for the Activation of CD40 by Membrane-presented CD40 Ligand versus Soluble Agonist
by: Khalidah Ibraheem, et al.
Published: (2018-07-01)
by: Khalidah Ibraheem, et al.
Published: (2018-07-01)
Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.
by: Miranda S Oakley, et al.
Published: (2009-08-01)
by: Miranda S Oakley, et al.
Published: (2009-08-01)
Mast Cell-Derived Exosomes Promote Th2 Cell Differentiation via OX40L-OX40 Ligation
by: Fei Li, et al.
Published: (2016-01-01)
by: Fei Li, et al.
Published: (2016-01-01)
Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma
by: Xianlong Chen, et al.
Published: (2022-07-01)
by: Xianlong Chen, et al.
Published: (2022-07-01)
CD40 ligand (CD154) incorporated into HIV virions induces activation-induced cytidine deaminase (AID) expression in human B lymphocytes.
by: Marta Epeldegui, et al.
Published: (2010-07-01)
by: Marta Epeldegui, et al.
Published: (2010-07-01)
Similar Items
-
Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
by: Dawei Cui, et al.
Published: (2019-01-01) -
Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
by: Ayaka Sato, et al.
Published: (2025-01-01) -
Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis
by: Xiaoling Zhou, et al.
Published: (2022-01-01) -
Activation of OX40 and CD27 Costimulatory Signalling in Sheep through Recombinant Ovine Ligands
by: José Manuel Rojas, et al.
Published: (2020-06-01) -
Role of OX40 and its ligand as costimulatory modulators in cancer immunotherapy
by: Aliya I Sani, et al.
Published: (2021-07-01)
